Swiss National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128M | Buy |
|
|||||
|
2025
Q1 | $98.3M | Buy |
|
|||||
|
2024
Q4 | $85.3M | Sell |
|
|||||
|
2024
Q3 | $103M | Buy |
|
|||||
|
2024
Q2 | $91M | Sell |
|
|||||
|
2024
Q1 | $56.2M | Sell |
|
|||||
|
2023
Q4 | $74.8M | Sell |
|
|||||
|
2023
Q3 | $70.9M | Sell |
|
|||||
|
2023
Q2 | $85M | Sell |
|
|||||
|
2023
Q1 | $97.8M | Buy |
|
|||||
|
2022
Q4 | $116M | Sell |
|
|||||
|
2022
Q3 | $105M | Buy |
|
|||||
|
2022
Q2 | $76M | Buy |
|
|||||
|
2022
Q1 | $84.6M | Buy |
|
|||||
|
2021
Q4 | $76.6M | Sell |
|
|||||
|
2021
Q3 | $87.7M | Sell |
|
|||||
|
2021
Q2 | $80.8M | Buy |
|
|||||
|
2021
Q1 | $63.1M | Buy |
|
|||||
|
2020
Q4 | $56.9M | Sell |
|
|||||
|
2020
Q3 | $65.1M | Buy |
|
|||||
|
2020
Q2 | $66M | Buy |
|
|||||
|
2020
Q1 | $47.1M | Buy |
|
|||||
|
2019
Q4 | $40.4M | Sell |
|
|||||
|
2019
Q3 | $29.4M | Buy |
|
|||||
|
2019
Q2 | $22.6M | Buy |
|
|||||
|
2019
Q1 | $28.3M | Buy |
|
|||||
|
2018
Q4 | $21.5M | Buy |
|
|||||
|
2018
Q3 | $25.3M | Sell |
|
|||||
|
2018
Q2 | $29.2M | Buy |
|
|||||
|
2018
Q1 | $33.7M | Sell |
|
|||||
|
2017
Q4 | $41.5M | Buy |
|
|||||
|
2017
Q3 | $16.2M | Hold |
|
|||||
|
2017
Q2 | $11M | Buy |
|
|||||
|
2017
Q1 | $6.54M | Buy |
|
|||||
|
2016
Q4 | $4.75M | Sell |
|
|||||
|
2016
Q3 | $14.4M | Sell |
|
|||||
|
2016
Q2 | $11.9M | Buy |
|
|||||
|
2016
Q1 | $11.9M | Buy |
|
|||||
|
2015
Q4 | $13M | Buy |
|
|||||
|
2015
Q3 | $10.8M | Buy |
|
|||||
|
2015
Q2 | $14.6M | Buy |
|
|||||
|
2015
Q1 | $8.65M | Buy |
|
|||||
|
2014
Q4 | $6.95M | Buy |
|
|||||
|
2014
Q3 | $5.3M | Buy |
|
|||||
|
2014
Q2 | $3.84M | Sell |
|
|||||
|
2014
Q1 | $4.26M | Buy |
|
|||||
|
2013
Q4 | $3.16M | Buy |
|
|||||
|
2013
Q3 | $3.11M | Sell |
|
|||||
|
2013
Q2 | $1.57M | Buy |
|